Video

Dr. Zillioux discusses same-day discharge for FPMRS procedures

Author(s):

Urology Times staff

"Same-day discharge is safe and feasible across a broad spectrum of FPMRS cases," says Jacqueline Zillioux, MD.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Jacqueline Zillioux, MD, discusses the recent Neurourology & Urodynamics paper, “Same-day discharge across FPMRS surgical cases is safe and feasible: A 10-year single-surgeon experience.” Zillioux is a urology FPMRS fellow at Cleveland Clinic.

      Related Videos
      Anna Myers, CNP, answers a question during a Zoom video interview
      Urology CNP discusses sensitivity in communication, physical exam
      Study data point to gender disparities in oncology research citations
      Study data point to gender disparities in oncology research citations
      Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
      Matthew Galsky, MD, on patient selection for perioperative durvalumab/chemo in MIBC
      Ekene Enemchukwu, MD, on guideline-associated trends in OAB therapy use
      Ekene Enemchukwu, MD, on guideline-associated trends in OAB therapy use
      Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
      Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
      Karyn S. Eilber, MD, answers a question during a Zoom video interview
      Karyn S. Eilber, MD, on patient counseling for onabotA treatment for OAB
      Woman at doctor | Image Credit: © rocketclips - stock.adobe.com
      Optimizing onabotA for OAB: What are some common misconceptions?
      Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
      Ian Metzler, MD, on the role for telemedicine, digital health tools in stone disease
      Nitin Yerram, MD, highlights new resource center for patients with renal cell carcinoma
      Nitin Yerram, MD, highlights new resource center for patients with renal cell carcinoma
      Perry Xu, MD, answers a question during Zoom video interview
      Perry Xu, MD, discusses PCNL’s role in the age of minimally invasive URS
      Related Content
      Hospital waiting room with reception counter at medical facility | Image Credit: © visoot - stock.adobe.com
      April 5th 2025

      Vaginal prolapse repair and sling surgery significantly reduce UUI

      Christina M. Mezes, DO Catherine A. Matthews, MD
      "The biggest message from this study is that 60% can expect resolution of UUI, simply by fixing the prolapse and placing a sling, which is not normally indicated for UUI," according to Christina M. Mezes, DO, and Catherine A. Matthews, MD.
      Speaking of Urology: Dr. Winter on the use of vaginal estrogen
      July 24th 2024

      Speaking of Urology: Dr. Winter on the use of vaginal estrogen

      Urology Times staff
      In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
      FDA grants marketing authorization to at-home diagnostic test for STIs
      March 28th 2025

      FDA grants marketing authorization to at-home diagnostic test for STIs

      Hannah Clarke
      The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.
      Dr. Malik evaluates quality of Reddit content on recurrent UTIs
      March 17th 2022

      Dr. Malik evaluates quality of Reddit content on recurrent UTIs

      Urology Times staff
      “I think we as urologists have to be proactive in providing information to our patients so that they avoid financial harm and potentially bodily harm from this sort of misinformation,” says Rena D. Malik, MD.
      FDA approves gepotidacin for uncomplicated UTI
      March 25th 2025

      FDA approves gepotidacin for uncomplicated UTI

      Hannah Clarke
      The approval is supported by data from the phase 3 EAGLE-2 and EAGLE-3 trials.
      Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome
      March 11th 2025

      Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome

      Hannah Clarke
      "The findings from this study will help us understand sunobinop’s potential as a possible new treatment option for this chronic disorder,” said Craig Landau, MD.
      © 2025 MJH Life Sciences

      All rights reserved.